Renal oncocytoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Homa}} {{SC}} | {{CMG}}; {{AE}}{{Homa}} {{SC}} | ||
==Overview== | ==Overview== | ||
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral). | |||
==Risk Factors== | ==Risk Factors== | ||
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral). | |||
==References== | ==References== | ||
Revision as of 20:08, 22 October 2019
|
Renal oncocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal oncocytoma risk factors On the Web |
|
American Roentgen Ray Society Images of Renal oncocytoma risk factors |
|
Risk calculators and risk factors for Renal oncocytoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).
Risk Factors
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).